Internal Medicine, Medical Oncology · Wilson, NC
NPI
1649634486
Since 2016
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
2624 Ortho Dr W
Wilson, NC, 27893
Phone (252) 991-5261
Groups this clinician bills Medicare through
Medicare paid, 2024
$858K
50,717 services
Medicare patients, 2024
329
Average age 75
Drug cost, 2024
$5.2M
1,482 prescriptions
Company payments, 2025
$3,561
From 59 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Andre Dixon was code J0897 (injection, denosumab, 1 mg), 7,032 times for 46 patients. In total Andre Dixon billed 50,717 services in 89 codes, and Medicare paid $858K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-09-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 7,032 | 46 | $20.63 | $145K |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 2,900 | 23 | $15.64 | $45K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,116 | 16 | $0.09 | $99.61 |
| 85025 Blood Count | Office | 731 | 174 | $7.61 | $5,563 |
| 36415 Venipuncture Blood Collection | Office | 427 | 184 | $6.86 | $2,929 |
| 99214 Office E&M - Established | Office | 388 | 177 | $89.32 | $35K |
| 96372 Injection Administration | Office | 312 | 78 | $10.15 | $3,167 |
| 99232 Hospital E&M - Subsequent | Facility | 178 | 54 | $59.10 | $11K |
| 96367 Intravenous Infusion, Hydration | Office | 172 | 18 | $20.97 | $3,607 |
| 96413 Chemotherapy Administration | Office | 122 | 14 | $94.37 | $12K |
| 99205 Office E&M - New | Office | 120 | 120 | $154.50 | $19K |
| 80053 Clinical Chemistry | Office | 96 | 26 | $10.35 | $994 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 90 | 12 | $0.90 | $80.55 |
| 96365 Intravenous Infusion, Hydration | Office | 75 | 49 | $44.20 | $3,315 |
| J3489 Injection, zoledronic acid, 1 mg | Office | 60 | 12 | $5.23 | $314 |
By year: 2022 $497K for 30,379 services; 2023 $626K for 43,757 services; 2024 $858K for 50,717 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 731 | 174 | $7.61 | $5,563 |
| 36415 Venipuncture Blood Collection | 427 | 184 | $6.86 | $2,929 |
| 80053 Clinical Chemistry | 96 | 26 | $10.35 | $994 |
Medicare prescription drug claims, 2024
In 2024, the drug Andre Dixon prescribed most often to Medicare patients was Anastrozole, with 131 prescriptions and refills. In total Andre Dixon wrote 1,482 Medicare prescriptions that cost $5.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 131 | 267 | 31 | $2,217 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 69 | 69 | 11 | $760 |
| Prednisone Generic | 61 | 67 | 14 | $614 |
| Eliquis Apixaban | 58 | 58 | 15 | $33K |
| Abiraterone Acetate Generic | 57 | 57 | Under 11 | $60K |
| Letrozole Generic | 55 | 64 | Under 11 | $779 |
| Procrit Epoetin Alfa | 52 | 52 | 24 | $170K |
| Dexamethasone Generic | 51 | 51 | 18 | $1,108 |
| Udenyca Pegfilgrastim-Cbqv | 45 | 45 | 12 | $198K |
| Xgeva Denosumab | 44 | 44 | Under 11 | $141K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 34 | 34 | Under 11 | $569 |
| Verzenio Abemaciclib | 30 | 30 | Under 11 | $456K |
| Prolia Denosumab | 26 | 157 | 17 | $44K |
| Opdivo Nivolumab | 23 | 23 | Under 11 | $291K |
| Jakafi Ruxolitinib Phosphate | 23 | 23 | Under 11 | $405K |
Brand drugs: 645 claims; generic drugs: 837 claims; opioid claims: 147.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Andre Dixon $3,561 ($3,561 in general payments such as food, travel and fees) from 59 companies. The largest payer was Dendreon Pharmaceuticals LLC with $354.
| Company | Payments | Amount |
|---|---|---|
| Dendreon Pharmaceuticals LLC | 14 | $354 |
| Merck Sharp & Dohme LLC MRK | 8 | $214 |
| Abbvie Inc. ABBV | 7 | $193 |
| Pfizer Inc. PFE | 9 | $180 |
| Novartis Pharmaceuticals Corporation NVS | 8 | $147 |
| Janssen Biotech, Inc. JNJ | 7 | $140 |
| ASD Specialty Healthcare, LLC | 1 | $132 |
| Daiichi Sankyo Inc. 4568.T | 5 | $122 |
| Servier Pharmaceuticals LLC | 6 | $111 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 3 | $109 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.